Q2 2017 Intersect ENT Inc Earnings Call

1/8/2017 16:30

Conference Call Intersect ENT Inc

Intersect ENT Inc Conference call or earnings call will be held on Aug 1, 2017 During the earnings conference call's session Intersect ENT Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conference call the bridge access number and key in the PIN code, Contact Intersect ENT Inc for this information
Schedule a conference call with QCONF and get 5 free conference calls.
We are a commercial stage drug-device company committed to improving the quality of life for patients with ear, nose and throat conditions. We have developed a drug releasing bioabsorbable implant technology that enables targeted and sustained release of therapeutic agents. This targeted drug delivery technology is designed to allow ear, nose and throat, or ENT, physicians to improve patient care. Our approved and in-development products are designed to treat the spectrum of needs among the estimated 3.5 million U.S. patients who are managed by ENT physicians for chronic sinusitis, one of the most prevalent chronic diseases in the United States and one of the most costly conditions for U.S. employers. Chronic sinusitis patients include those needing and electing surgery, those who have not had sinus surgery and those that have had one or more surgeries but continue to suffer from symptoms.    
Read more Conference Call

Intersect ENT Inc (XENT)

1555 Adams Drive, Menlo Park California 94025, United States